
|Slideshows|July 13, 2017
Prescription Opioid Use and Misuse: 10 Myths or Facts
Author(s)Steven A. King, MD, MS
Do you know myth from fact about recent patterns of US opioid prescribing? Find out with these 10 statements.
Advertisement
The CDC recently published a report on changes in national- and county-level opioid prescribing between 2006 and 2015.See if you know Myths from Facts about the ebb and flow of opioid use and misuse in the United States. Click through this slide challenge created by pain specialist Steven A. King, MD, MS. Image credits: Slide background: ©amasterphotographer/Shutterstock.com; Unicorn, ©Lifeking/Shutterstock.com; Green check:©MisterEMil/Shutterstock.com
References:
- Guy GP, Zhang K, Bohm MK, et al. Vital signs: changes in opioid prescribing in the United States, 2006-20015. MMWR Morb Mortal Wkyly Rep. 2017;66:697-704.
https://www.cdc.gov/mmwr/volumes/66/wr/mm6626a4.htm - Shah A, Hayes CJ, Martin BC. Characteristics of initial prescription episodes and likelihood of long-term opioid use-United States, 2006-2015. Morb Mortal Wkly Rep. 2017;66:265-269.
https://www.cdc.gov/mmwr/volumes/66/wr/mm6610a1.htm - CDC. Opioid overdose. Prescribing Data.
https://www.cdc.gov/drugoverdose/data/prescribing.html - Davis MA, Lin LA, Liu H, et al. Prescription opioid use among adults with mental disorders in the United States. J Am Board Fam Med. 2017;30(4);doi:10.3122/jabfm.2017.04.170112.
Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
Semaglutide Boosts Quality of Life in T2D and CKD, FLOW Trial Analysis Finds
2
5 FDA Decisions for Primary Care to Know from May 2026
3
Shared Decision-Making and MHT Safety in Women with VMS
4
FDA Issues Complete Response Letter for Cingulate ADHD Drug CTx-1301
5




























































































































































